Search Results - Olena Barbash
- Showing 1 - 4 results of 4
-
1
Phase I/II study of the clinical activity and safety of GSK3326595 in patients with myeloid neoplasms by Justin Watts, Mark D. Minden, Kimo Bachiashvili, Andrew M. Brunner, Sameem Abedin, Timothy Crossman, Magdalena Zajac, Veronica Moroz, Jacqueline L. Egger, Aarti Tarkar, Brandon E. Kremer, Olena Barbash, Gautam Borthakur
Published in Therapeutic Advances in Hematology (2024-09-01)Get full text
Article -
2
624 Targeting Type I arginine methyltransferases promotes T cell mediated antitumor immune responses by Guangchun Han, Linghua Wang, Patrick Hwu, Weiyi Peng, Chunyu Xu, Shane O’Brien, Yunfei Wang, Jiakai Hou, Leilei Shi, Leila Williams, Andrew Fedoriw, Kimberly Smitheman, Christian Sherk, Satyajit Rajapurkar, Jenny Laraio, Qin Feng, Mark Bedford, Olena Barbash, Ryan Kruger, Helai Mohammad
Published in Journal for ImmunoTherapy of Cancer (2021-11-01)Article -
3
BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models. by Anastasia Wyce, Gopinath Ganji, Kimberly N Smitheman, Chun-Wa Chung, Susan Korenchuk, Yuchen Bai, Olena Barbash, BaoChau Le, Peter D Craggs, Michael T McCabe, Karen M Kennedy-Wilson, Lydia V Sanchez, Romain L Gosmini, Nigel Parr, Charles F McHugh, Dashyant Dhanak, Rab K Prinjha, Kurt R Auger, Peter J Tummino
Published in PLoS ONE (2013-01-01)Get full text
Article -
4
TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma by Tatiana Erazo, Chiara M. Evans, Daniel Zakheim, Eren L. Chu, Alice Yunsi Refermat, Zahra Asgari, Xuejing Yang, Mariana Da Silva Ferreira, Sanjoy Mehta, Marco Vincenzo Russo, Andrea Knezevic, Xi-Ping Zhang, Zhengming Chen, Myles Fennell, Ralph Garippa, Venkatraman Seshan, Elisa de Stanchina, Olena Barbash, Connie Lee Batlevi, Christina S. Leslie, Ari M. Melnick, Anas Younes, Michael G. Kharas
Published in Nature Communications (2022-09-01)Get full text
Article
